Skip to main content
. Author manuscript; available in PMC: 2017 Jul 3.
Published in final edited form as: Am J Med Genet. 1987 Jul;27(3):645–649. doi: 10.1002/ajmg.1320270318

TABLE I.

Percentage of Cells With Aberrations Treated With 20 ng/ml Mitomycin C for 96 Hr

Subject group Chromatid and chromosome aberrations Chromatid aberrations Chromosome aberrations
J.J. 18 16 2   
Control      5.3      4.6 0.7
(N = 12)